High prevalence of gastric cancer in families with germline TP53 mutations

被引：0
|
作者：
Masciari, Serena
Dewanwala, Akritti
Stoffel, Elena M.
Li, Frederick
Garber, Judy E.
Syngal, Sapna
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：A67 / A67
页数：1
相关论文
共 50 条
  • [1] High prevalence of germline TP53 mutations in young osteosarcoma cases
    Mirabello, Lisa J.
    Yeager, Meredith
    Mai, Phuong L.
    Gastier-Foster, Julie
    Gorlick, Richard
    Khanna, Chand
    Patino-Garcia, Ana
    Sierrasesumaga, Luis
    Lecanda, Fernando
    Andrulis, Irene L.
    Wunder, Jay S.
    Gokgoz, Nalan
    Barkauskas, Donald A.
    Zhang, Xijun
    Vogt, Aurelie
    Jones, Kristine
    Boland, Joseph F.
    Chanock, Stephen J.
    Savage, Sharon A.
    CANCER RESEARCH, 2015, 75
  • [2] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [3] Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations
    Choong, S. S.
    Latiff, Z. A.
    Mohamed, M.
    Lim, L. L. W.
    Chen, K. S.
    Vengidasan, L.
    Razali, H.
    Rahman, E. J. Abdul
    Ariffin, H.
    CLINICAL GENETICS, 2012, 82 (06) : 564 - 568
  • [4] Germline mutations in the TP53 gene
    Eeles, RA
    CANCER SURVEYS, 1995, 25 : 101 - 124
  • [5] Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer
    Sheng, Shuyan
    Xu, Ye
    Guo, Yonghai
    Yao, Lu
    Hu, Li
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (02) : 487 - 495
  • [6] Prevalence of germline TP53 mutations in HER2+breast cancer patients
    Rath, Michelle G.
    Masciari, Serena
    Gelman, Rebecca
    Miron, Alexander
    Miron, Penelope
    Foley, Kathleen
    Richardson, Andrea L.
    Krop, Ian E.
    Verselis, Sigitas J.
    Dillon, Deborah A.
    Garber, Judy E.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (01) : 193 - 198
  • [7] Prevalence of germline TP53 mutations in HER2+ breast cancer patients
    Michelle G. Rath
    Serena Masciari
    Rebecca Gelman
    Alexander Miron
    Penelope Miron
    Kathleen Foley
    Andrea L. Richardson
    Ian E. Krop
    Sigitas J. Verselis
    Deborah A. Dillon
    Judy E. Garber
    Breast Cancer Research and Treatment, 2013, 139 : 193 - 198
  • [8] Cancer phenotype in 19 families with TP53 mutations
    Birch, JM
    Varley, JM
    Kelsey, AM
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 33 - 33
  • [9] Clinical implications of germline mutations in breast cancer: TP53
    Katherine Schon
    Marc Tischkowitz
    Breast Cancer Research and Treatment, 2018, 167 : 417 - 423
  • [10] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
    Finkova, Alena
    Vazna, Alzbeta
    Hrachovina, Ondrej
    Bendova, Sarka
    Prochazkova, Kamila
    Sedlacek, Zdenek
    CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
12345